ACADL
protein-codingacyl-CoA dehydrogenase long chain, the group of Acyl-CoA dehydrogenase family
Gene summary
The protein encoded by this gene belongs to the acyl-CoA dehydrogenase family, which is a family of mitochondrial flavoenzymes involved in fatty acid and branched chain amino-acid metabolism. This protein is one of the four enzymes that catalyze the initial step of mitochondrial beta-oxidation of straight-chain fatty acid. Defects in this gene are the cause of long-chain acyl-CoA dehydrogenase (LCAD) deficiency, leading to nonketotic hypoglycemia. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~38.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0020531
Submitter: ClinGen
ACADL was first reported in relation to autosomal recessive long chain acyl-CoA dehydrogenase deficiency in 1993 (Yamaguchi S, et al., 1993, PMID: 8356011). Initial reports of LCAD deficient patients (PMIDs 1945557 and 4022672) were subsequently found to have a VLCAD deficiency and/or no pathogenic LCAD variants were identified. More recent reports (PMID 24591516) suggest that LCAD deficiency may manifest primarily as pulmonary disease, however the only identified variant remains a common polymorphism (Lys333Gln) for which there is some evidence of a functional impact (PMID 32389575). In summary, there is convincing evidence disputing the relationship between ACADL and autosomal recessive long chain acyl-CoA dehydrogenase deficiency. More evidence is needed to either support or refute the role ACADL plays in this disease. This gene-disease pair was originally evaluated by the FAO GCEP on 09/25/2018. It was reevaluated on 01/15/2021 and 03/07/2024. As a result of this reevaluation, the classification did not change as no new information is contributing to the classification.
Inheritance Pattern: AR
Disease ID:MONDO:0012580
Submitter: PanelApp Australia
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ACADL variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001608.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 12 | 1 | 13 | |||
| missense | 62 | 6 | 68 | |||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 1 | 2 | 3 | |||
| splice donor/acceptor (+/-2bp) | 3 | 3 | ||||
| Total | 0 | 0 | 66 | 20 | 1 | 87 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001599.1 | 11 | MANE Select | |
| Ensembl | ENSP00000233710.3 | 11 | MANE Select | |
| Ensembl | ENSP00000532388.1 | 10 | Standard | |
| Ensembl | ENSP00000532388.1 | 10 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Fatty acid degradation - Homo sapiens (human)
- PPAR signaling pathway - Homo sapiens (human)
- Long chain acyl-CoA dehydrogenase deficiency (LCAD)
- Trifunctional protein deficiency
- Carnitine palmitoyl transferase deficiency (II)
Biological Process
- temperature homeostasis
- fatty acid beta-oxidation
- carnitine metabolic process, CoA-linked
- fatty acid beta-oxidation using acyl-CoA dehydrogenase
- carnitine catabolic process
Molecular Function
- fatty-acyl-CoA binding
- acyl-CoA dehydrogenase activity
- long-chain-acyl-CoA dehydrogenase activity
- palmitoyl-CoA oxidase activity
- flavin adenine dinucleotide binding
Cellular Component
- mitochondrion
- mitochondrial matrix
- mitochondrial membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000233710
- Coding exons
- 11
- Length
- 37553
- Individuals with no LoFs
- 125577
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 170
- Defined
- 125747
- p
- 0.000676
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.856 | 196 | 233 | 0.842 | 0.0000114 | 2797 |
| Missense (PolyPhen) | 74 | 81.338 | 0.90979 | 1044 | ||
| Synonymous | 1.79 | 61 | 81.5 | 0.748 | 0.00000418 | 815 |
| Loss of Function | 0.913 | 21 | 26.0 | 0.807 | 0.00000132 | 300 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00037 | 0.00037 | rare |
| Latino/Admixed American | 0.00055 | 0.00055 | rare |
| Ashkenazi Jewish | 0.00060 | 0.00060 | rare |
| East Asian | 0.00038 | 0.00038 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00081 | 0.00081 | rare |
| South Asian | 0.00085 | 0.00085 | rare |
| Other | 0.0023 | 0.0023 | notable |
dbNSFP Gene Annotations
Source:
Recessive Scores
- pRec
- 0.326
Intolerance Scores
- LoFtool
- 0.344
- RVIS EVS
- -0.36
- RVIS percentile EVS
- 29.16
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.296
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |